-
Emraclidine (developmental code
names CVL-231, PF-06852231) is an
investigational antipsychotic for the
treatment of both
schizophrenia and Alzheimer's...
-
treatments at
varying stages of
development include:
Tavapadon (Parkinson's)
Emraclidine (Schizophrenia, Alzheimer's)
Darigabat (Epilepsy) CVL-871 (Dementia,...
- molecule, but its
chemical structure does not seem to have been disclosed.
Emraclidine NBI-1117568
Xanomeline "NS 136". AdisInsight.
Springer Nature Switzerland...
-
methionil (DB-103, LY-2140023, LY-2812223) – mGluR2 and mGluR3
agonist Emraclidine (CVL-231) – M4
muscarinic acetylcholine receptor positive allosteric...
- molecule, but its
chemical structure does not seem to have been disclosed.
Emraclidine NBI-1117568 NS-136 Xanomeline/trospium "ML 007". AdisInsight. Springer...
-
behind xanomeline/trospium (KarXT) (Karuna Therapeutics) with 8.4 and
emraclidine (Cerevel Therapeutics) with 12.7, both of
which were in
clinical trials...
- (developed by
Karuna Therapeutics) and the 12.7-point
improvement seen with
Emraclidine (developed by
Cerevel Therapeutics), both of
which were also in clinical...
-
Carbachol CMI-936 NBI-1117568 (HTL-0016878) ML-007
Oxotremorine Xanomeline Emraclidine (CVL-231, PF-06852231) LY-2033298 NS-136 SUVN-L3307032 VU-0152100 (ML-108)...
